title: [Clinical experience in using agomelatin (valdoxan) in the neurological practice].
abstract: The author presents the own clinical experience of the use of agomelatin (valdoxan) in the complex treatment of patients with ischemic stroke, migraine, fibromyalgia and during "drug holidays" after the withdrawal of benzodiazepines. In all cases of comorbid neurological diseases and clinically diagnosed insomnia and depression, valdoxan demonstrated its efficacy and safety.
authors.forename: Ia I
authors.initials: IaI
authors.lastname: Levin
mesh_terms: D000081:Acetamides / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D001569:Benzodiazepines / Q000627:therapeutic use; D003863:Depression / Q000150:complications; D005260:Female; D005356:Fibromyalgia / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000150:complications / Q000188:drug therapy*; D007319:Sleep Initiation and Maintenance Disorders / Q000150:complications; D020521:Stroke / Q000150:complications / Q000188:drug therapy*; D028761:Withholding Treatment; D009281:Naphthalenes
chemical_list: D000081:Acetamides; D001569:Benzodiazepines; D006993:Hypnotics and Sedatives; C084711:agomelatine; D009281:Naphthalenes